Stockreport

Soligenix stock soars 106% on FDA orphan drug status [Seeking Alpha]

Soligenix, Inc.  (SNGX) 
NASDAQ:AMEX Investor Relations: soligenix.com/investors
PDF The biotech company said the FDA granted the designation to the vaccine's active ingredient for the prevention and post-exposure prophylaxis against Marburg marburgviru [Read more]